Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

15.1%

231 terminated/withdrawn out of 1531 trials

Success Rate

80.5%

-6.1% vs industry average

Late-Stage Pipeline

9%

133 trials in Phase 3/4

Results Transparency

41%

394 of 951 completed trials have results

Key Signals

199 recruiting394 with results116 terminated115 withdrawn

Enrollment Performance

Analytics

N/A
690(60.5%)
Phase 2
159(13.9%)
Phase 1
133(11.7%)
Phase 4
107(9.4%)
Phase 3
26(2.3%)
Early Phase 1
25(2.2%)
1140Total
N/A(690)
Phase 2(159)
Phase 1(133)
Phase 4(107)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1531)

Showing 20 of 1531 trials
NCT06213649Phase 3Recruiting

Parasitic Ulcer Treatment Trial

Role: collaborator

NCT07782398Not ApplicableRecruiting

Momentary Coping Prompts and Hair Steroids in College Students

Role: lead

NCT06224829Not ApplicableRecruiting

Response to Massage in Neck Pain

Role: lead

NCT05065008Not ApplicableCompleted

The Roles of Gut Microbiome in UTI Susceptible Women

Role: lead

NCT07636447Not ApplicableRecruiting

Alcohol Sensitivity Among Older Adults Who Consume Alcohol

Role: lead

NCT07446192Not ApplicableRecruiting

Magnetoencephalography (MEG) Pilot Study

Role: lead

NCT07597070Phase 2Not Yet Recruiting

Universal Immunization to Fortify Immunotherapy Efficacy and Response

Role: lead

NCT07281378Not ApplicableNot Yet Recruiting

Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.

Role: lead

NCT07492316Phase 1Active Not Recruiting

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Role: lead

NCT07843264Phase 4Not Yet Recruiting

PPI Dosing Per CYP2C19 Genotype

Role: lead

NCT07799805Not ApplicableRecruiting

Deconstructing Maternal Burdens: Doulas and the Community Unite for Health

Role: lead

NCT05371041Not ApplicableActive Not Recruiting

Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression

Role: lead

NCT05913713Not ApplicableCompleted

HIIT Following Breast Cancer Chemotherapy

Role: lead

NCT05047172Phase 3Active Not Recruiting

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Role: lead

NCT06863480Phase 1Recruiting

Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events

Role: lead

NCT04275557Active Not Recruiting

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Role: collaborator

NCT05353530Phase 1Active Not Recruiting

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma

Role: lead

NCT06389591Phase 1Recruiting

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

Role: lead

NCT07395609Not ApplicableRecruiting

High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive Decline

Role: lead

NCT07031765Phase 1Active Not Recruiting

Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

Role: lead